Northern Capital Management LLC lessened its position in Monsanto Company (NYSE:MON) by 4.6% in the second quarter, according to its most recent disclosure with the SEC. The firm owned 26,105 shares of the basic materials company’s stock after selling 1,265 shares during the period. Northern Capital Management LLC’s holdings in Monsanto were worth $3,090,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently made changes to their positions in MON. Linscomb & Williams Inc. grew its stake in Monsanto by 1.1% in the first quarter. Linscomb & Williams Inc. now owns 11,424 shares of the basic materials company’s stock valued at $1,293,000 after acquiring an additional 120 shares during the period. Wells Fargo & Company MN grew its stake in Monsanto by 18.2% in the first quarter. Wells Fargo & Company MN now owns 1,403,245 shares of the basic materials company’s stock valued at $158,848,000 after acquiring an additional 216,424 shares during the period. Canada Pension Plan Investment Board grew its stake in Monsanto by 20.0% in the first quarter. Canada Pension Plan Investment Board now owns 1,218,175 shares of the basic materials company’s stock valued at $137,897,000 after acquiring an additional 203,000 shares during the period. Jennison Associates LLC grew its stake in Monsanto by 1.1% in the first quarter. Jennison Associates LLC now owns 296,205 shares of the basic materials company’s stock valued at $33,530,000 after acquiring an additional 3,209 shares during the period. Finally, Advisor Partners LLC grew its stake in Monsanto by 5.8% in the first quarter. Advisor Partners LLC now owns 7,073 shares of the basic materials company’s stock valued at $801,000 after acquiring an additional 387 shares during the period. 74.79% of the stock is owned by hedge funds and other institutional investors.

Shares of Monsanto Company (NYSE MON) opened at 117.85 on Thursday. The firm has a 50 day moving average price of $117.21 and a 200 day moving average price of $116.39. The company has a market capitalization of $51.77 billion, a price-to-earnings ratio of 25.45 and a beta of 1.07. Monsanto Company has a 52 week low of $97.35 and a 52 week high of $118.97.

Monsanto (NYSE:MON) last issued its earnings results on Wednesday, June 28th. The basic materials company reported $1.93 EPS for the quarter, beating the consensus estimate of $1.74 by $0.19. Monsanto had a return on equity of 45.26% and a net margin of 14.11%. The business had revenue of $4.23 billion for the quarter, compared to the consensus estimate of $4.18 billion. During the same period last year, the business posted $2.17 EPS. The company’s revenue was up 1.0% compared to the same quarter last year. Equities analysts forecast that Monsanto Company will post $4.89 EPS for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 27th. Shareholders of record on Friday, October 6th will be paid a dividend of $0.54 per share. The ex-dividend date of this dividend is Thursday, October 5th. This represents a $2.16 annualized dividend and a yield of 1.83%. Monsanto’s dividend payout ratio is 46.75%.

TRADEMARK VIOLATION NOTICE: This story was originally posted by Daily Political and is the property of of Daily Political. If you are reading this story on another publication, it was copied illegally and republished in violation of U.S. and international copyright laws. The legal version of this story can be viewed at https://www.dailypolitical.com/2017/09/14/northern-capital-management-llc-trims-holdings-in-monsanto-company-mon.html.

In other Monsanto news, EVP Robert T. Fraley sold 52,410 shares of the stock in a transaction on Monday, July 10th. The stock was sold at an average price of $117.95, for a total transaction of $6,181,759.50. The sale was disclosed in a filing with the SEC, which is available through this link. Also, EVP Steven Mizell sold 11,300 shares of the stock in a transaction on Monday, July 3rd. The shares were sold at an average price of $118.57, for a total value of $1,339,841.00. Following the sale, the executive vice president now owns 55,011 shares in the company, valued at $6,522,654.27. The disclosure for this sale can be found here. Company insiders own 0.79% of the company’s stock.

A number of research firms have recently weighed in on MON. BidaskClub upgraded Monsanto from a “sell” rating to a “hold” rating in a report on Thursday, June 29th. BMO Capital Markets restated a “buy” rating and issued a $128.00 target price on shares of Monsanto in a report on Friday, September 1st. Vetr upgraded Monsanto from a “hold” rating to a “buy” rating and set a $122.35 target price on the stock in a report on Tuesday, June 27th. Zacks Investment Research upgraded Monsanto from a “hold” rating to a “buy” rating and set a $131.00 target price on the stock in a report on Tuesday, August 29th. Finally, Jefferies Group LLC lowered Monsanto from a “buy” rating to a “hold” rating and set a $128.00 target price on the stock. in a report on Wednesday, July 12th. One investment analyst has rated the stock with a sell rating, eleven have given a hold rating and eight have assigned a buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus price target of $123.43.

Monsanto Profile

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

Institutional Ownership by Quarter for Monsanto (NYSE:MON)

Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with MarketBeat.com's FREE daily email newsletter.